Showing 61,641 - 61,660 results of 226,405 for search '(( a ((((mean decrease) OR (a decrease))) OR (linear decrease)) ) OR ( a large decrease ))', query time: 1.44s Refine Results
  1. 61641
  2. 61642
  3. 61643
  4. 61644
  5. 61645
  6. 61646
  7. 61647
  8. 61648
  9. 61649

    The use of NSAF to compare protein abundance in replicate viral aniPOND data sets and between different infection conditions. by Jessica E. Packard (16641690)

    Published 2023
    “…Proteins that had at least 4-fold decreased association with PCNA-I1 are presented in <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1011539#ppat.1011539.g009" target="_blank">Fig 9B</a>. …”
  10. 61650
  11. 61651

    Supplementary Material for: Risk Factors Assessed in Adolescence and the Later Risk of Stroke in Men: A 33-Year Follow-Up Study by Högström G. (3683686)

    Published 2017
    “…<b><i>Results:</i></b> During a median follow-up period of 33 years 6,180 ischemic strokes and 2,104 hemorrhagic strokes were diagnosed in the cohort at a mean age of 47.9 years. …”
  12. 61652

    DataSheet_1_A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults.pdf by Kun Xu (116877)

    Published 2023
    “…We retrieved 22 randomized controlled trials (RCTs), with a total of 3,404,696 older adults (aged over 60 years) participating, that were included in the meta-analysis. …”
  13. 61653

    Consequence of the normalization of <i>Dyrk1a</i> in glutamatergic neurons of Dp1Yey mice on animal cognition. by Véronique Brault (160595)

    Published 2021
    “…(D) Time spent exploring the two identical objects during the first object presentation session was decreased in Dp1Yey/<i>Dyrk1a</i><sup><i>C/+</i></sup> mice (Kruskal-Wallis One Way Analysis of Variance on Ranks, <i>p</i> = 0.02 with Dunn’s post hoc multiple comparison procedures versus control, Dp1Yey/<i>Dyrk1a</i><sup><i>C//+</i></sup> vs control, <i>p</i> = 0.02). …”
  14. 61654
  15. 61655
  16. 61656

    Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation by Aaqib H. Khan (9407159)

    Published 2022
    “…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). When stored in a closed environment, the microbubbles were observed to be stable for up to 30 days, with the concentration of the microbubble suspension decreasing from ∼2.81 × 10<sup>9</sup>/mL to ∼2.3 × 10<sup>6</sup>/mL and the size changing from 1.73 ± 0.2 to 1.45 ± 0.3 μm at the end of 30 days. …”
  17. 61657

    Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation by Aaqib H. Khan (9407159)

    Published 2022
    “…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). When stored in a closed environment, the microbubbles were observed to be stable for up to 30 days, with the concentration of the microbubble suspension decreasing from ∼2.81 × 10<sup>9</sup>/mL to ∼2.3 × 10<sup>6</sup>/mL and the size changing from 1.73 ± 0.2 to 1.45 ± 0.3 μm at the end of 30 days. …”
  18. 61658

    Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation by Aaqib H. Khan (9407159)

    Published 2022
    “…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). When stored in a closed environment, the microbubbles were observed to be stable for up to 30 days, with the concentration of the microbubble suspension decreasing from ∼2.81 × 10<sup>9</sup>/mL to ∼2.3 × 10<sup>6</sup>/mL and the size changing from 1.73 ± 0.2 to 1.45 ± 0.3 μm at the end of 30 days. …”
  19. 61659

    Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation by Aaqib H. Khan (9407159)

    Published 2022
    “…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). When stored in a closed environment, the microbubbles were observed to be stable for up to 30 days, with the concentration of the microbubble suspension decreasing from ∼2.81 × 10<sup>9</sup>/mL to ∼2.3 × 10<sup>6</sup>/mL and the size changing from 1.73 ± 0.2 to 1.45 ± 0.3 μm at the end of 30 days. …”
  20. 61660

    Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation by Aaqib H. Khan (9407159)

    Published 2022
    “…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). When stored in a closed environment, the microbubbles were observed to be stable for up to 30 days, with the concentration of the microbubble suspension decreasing from ∼2.81 × 10<sup>9</sup>/mL to ∼2.3 × 10<sup>6</sup>/mL and the size changing from 1.73 ± 0.2 to 1.45 ± 0.3 μm at the end of 30 days. …”